B55.1
Cutaneous leishmaniasis
Clinical Classification Guidelines
Medical Intelligence & Overview
Cutaneous leishmaniasis is a skin infection caused by the Leishmania parasite, transmitted through the bites of infected female sandflies. This condition leads to skin sores and ulcers, which can vary in appearance and severity. It is common in certain parts of the world, including parts of Central and South America, Africa, the Middle East, and Asia. Recognizing the symptoms and understanding the causes helps in managing the condition effectively.
Causes & Symptoms
Clinical Causes: Bite from infected female sandflies that carry the Leishmania parasite Living in or traveling to endemic regions where sandflies are prevalent Poor housing conditions that attract sandflies, such as inadequate screens or standing water Occupational exposure in rural or desert areas Weak immune system, which may increase vulnerability to infection
Key Symptoms: Initial skin lesions that develop at the site of the sandfly bite Raised, itchy skin sores or ulcers that may be moist or dry Lesions that are usually painless but can become inflamed or infected Scarring after the sores heal, which may be permanent In some cases, multiple sores may develop on different parts of the body Localized swelling or redness around the ulcers
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory tests. A health professional may perform skin smears, biopsies, or culture samples from the lesion to identify the Leishmania parasite. Molecular techniques such as PCR (polymerase chain reaction) can also be used to confirm the infection. The patient's travel history to endemic areas and the appearance of skin lesions are also critical factors in diagnosis.
Treatment Protocols: Treatment options aim to eliminate the Leishmania parasites and promote healing of skin lesions. These often include:
Clinical Advice & FAQs
Billing Guidance
Is B55.1 a billable ICD-10 code?
Yes, B55.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B55.1?
Clinical documentation must specify the nature of Cutaneous leishmaniasis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference